Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • CDK
    (1)
  • FGFR
    (1)
  • GSK-3
    (1)
  • MAPK
    (1)
  • NOD
    (1)
  • PI3K
    (1)
  • mTOR
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (3)
  • Inflammation
    (1)
Filter
Search Result
Results for "

T8884

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    5
    TargetMol | All_Pathways
hSMG-1 inhibitor 11j
T88841402452-15-6In house
hSMG-1 inhibitor 11j is a pyrimidine derivative. hSMG-1 inhibitor 11j is a potent and selective inhibitor of hSMG-1, IC50 = 0.11 nM. hSMG-1 inhibitor 11j exhibits >455-fold selectivity for hSMG-1 over mTOR (IC50=50 nM), PI3Kα/γ (IC50=92/60 nM) and CDK1/CDK2 (IC50=32/7.1 μM). hSMG-1 inhibitor 11j can be used for the research of cancer.
  • $163 TargetMol
In Stock
Size
QTY
NDI-101150
NMBS-2, NMBS2, NDI101150
T888402628486-22-4
NDI-101150 (NMBS-2) is an orally active, selective, and highly efficient hematopoietic progenitor kinase 1 (HPK1) inhibitor with anticancer activity. It inhibits BLNK phosphorylation and can be used in research on metastatic solid tumors.
  • $495
In Stock
Size
QTY
TYRA-300
TYRA-300-B01, TYRA300
T888412800223-30-5
TYRA-300 is an oral and selective FGFR3 inhibitor with an IC50 value of 11 nM and 25-fold, 14-fold, and 36-fold selectivity for FGFR1, FGFR2, and FGFR4, respectively, in the Ba/F3 cell line for the treatment of metastatic uroepithelial carcinomas (mUCs) and chondrodysplasia.
  • $392
In Stock
Size
QTY
AZD4144
T888462890191-41-8
AZD4144 is an NLRP3 inhibitor that can be used in research related to immune diseases.
  • $124
In Stock
Size
QTY
NVP-DFV890
T888492271394-34-2
NVP-DFV890 is an inhibitor targeting NLRP3 that can be used in immune disease-related research.
  • $1,920
10-14 weeks
Size
QTY